A Phase III Clinical Trial for Inactivated Enterovirus Type 71 Vaccine (Human Diploid Cell, KMB-17 Cell) in Chinese Infants and Children

Trial Profile

A Phase III Clinical Trial for Inactivated Enterovirus Type 71 Vaccine (Human Diploid Cell, KMB-17 Cell) in Chinese Infants and Children

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Apr 2015

At a glance

  • Drugs Enterovirus A vaccine (Primary)
  • Indications Coxsackievirus infections; Enterovirus A infections
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Most Recent Events

    • 17 Mar 2015 Based on results of this trial, an NDA for Sinovac's enterovirus 71 vaccine (enterovirus A vaccine) was filed with the China Food and Drug Administration, according to a media release.
    • 27 Feb 2014 Results published in the New England Journal of Medicine.
    • 01 Mar 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top